painless digestive endoscopy
Conditions
Interventions
group A:ciprofol+alfentanil 7µg/kg
group B:propofol+alfentanil 7µg/kg
group C:1.3 times the median effective dose of ciprofol + alfentanil 7µg/kg
group D:1.3 times the median effective dose of propofol + alfentanil 7µg/kg
Sponsors
The Second Affiliated Hospital of Hainan Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Patients who voluntarily undergo painless gastrointestinal endoscopy from July 10; 2. 2022 to December 31; 3. 2023, regardless of gender; 4. age 18 to 64 years old' 5. BMI 18 to 28 kg/?; 6. ASA I or II; 7. sign an informed consent form for anesthesia.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications to routine gastrointestinal endoscopy, contraindications to anesthesia; 2. esophageal cancer, and a history of taking medications that affect the results of the test, pregnant and lactating women; 3. those who require endotracheal; 4. Those with underlying esophageal pathology.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mean arterial pressure;oxygen saturation;wake up of time;time of departure from the hospital; | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of injection pain;incidence of nausea and vomiting;incidence of resuscitation agitation; | — |
Countries
China
Contacts
Public ContactHu Sun
the Second Affiliated Hospital of Hainan Medical University
Outcome results
None listed